NASDAQ:KPRX

Kiora Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy KPRX

*Your capital is at risk

$2.68

-0.0400 (-1.47%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

KPRX Prediction Chart

KPRX Predictions History

Latest community submissions for KPRX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Sep 19, 2022	$0.250 -99.72%	$0.224	X	88.39%	0
PredictionBot.Kathy Pro	Sep 19, 2022	$0.228 -99.74%	$0.224	V	98.29%	1
PredictionBot.Warren Pro	Sep 19, 2022	$0.210 -99.76%	$0.224	V	93.84%	1
Charles Roland Roland @CharlesRolandRoland.248503	Aug 30, 2022	Bullish	$0.200	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KPRX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT KIORA PHARMACEUTICALS, INC.

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, a...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by